Siemens expand its Walpole, Mass. Laboratory Diagnostic manufacturing facility

Siemens will invest $300M over the next four years

15-Dec-2016 - USA

Siemens Healthineers will invest around $300 million in its Walpole, Mass. laboratory diagnostics manufacturing and research and development facility.

"The expansion of the Walpole facility fits into the strategic growth plans for the company and allows us to increase our manufacturing footprint in the United States, the largest healthcare market in the world," said Bernd Montag, Chief Executive Officer, Siemens Healthineers. "The laboratory instruments and reagents developed and manufactured at the Siemens Healthineers Walpole facility impact patients and healthcare providers across the globe. "The Walpole facility currently employs more than 700 employees and is the main manufacturing facility for assays that run on the ADVIA® Centaur family of immunoassay instruments, and for consumables for its molecular and blood gas testing instruments. The facility will also manufacture assays to run on the immunoassay module of the AtellicaTM Solution, which is currently in development. R&D efforts at the site bring new tests to the diagnostics market to help physicians diagnose and treat disease.

"With a 37-year history of manufacturing products in Walpole, we saw an opportunity to leverage the local talent in the community to further our growth and expansion plans," said Franz Walt, President, Laboratory Diagnostics, Siemens Healthineers.

The company plans to upgrade and expand its existing 500,000 sq. ft. complex. Renovations to the existing facility will begin in the coming weeks. The expansion—which will include manufacturing, warehouse, office and lab space—is set to begin in the summer. Siemens Healthineers is committed to creating at least 400 positions. The company anticipates that it may ultimately create up to as many as 700 new permanent jobs to bring the total employment at the site to between 1,300 and 1,600 by 2026. These employees will join the 46,000 Siemens Healthineers around the world who enable healthcare providers to deliver excellent patient care.

Other news from the department business & finance

These products might interest you

VICI DBS ZeroAir

VICI DBS ZeroAir by VICI

Generate up to 30 L/min of analytically pure air yourself – for stable baseline GC-FID applications

Increase the sensitivity of your GC-FID analysis while reducing costs

zero air generators
Mars 6

Mars 6 by CEM

Everything under Control - with This Intelligent Microwave Digestion System

High Sample Throughput with Just One Click

microwave digestion systems
HYDROTHERM

HYDROTHERM by C. Gerhardt

Efficiency in food analysis: Safe and precise total fat determination made easy

Fully automatic acid hydrolysis in 90 minutes - validated for continuous operation

acid hydrolysis systems
APU sim

APU sim by Analytik Jena

APU sim Automatic Preparation Unit

APU sim The Clever Sample Preparation System According to Column Method

sample preparation systems
CrystalBreeder

CrystalBreeder by Technobis

CrystalBreeder: the next generation multi-reactor crystallization platform

Enhance your early stage solid state screening. New: controlled evaporation & vapor diffusion modes

OHAUS Laboratory equipment

OHAUS Laboratory equipment by Ohaus

Do More with OHAUS Laboratory Equipment

Do Not Limit Yourself to Just Measurement! Discover Ingenious Portfolio

lab equipment
Automatische XPR-Waagen

Automatische XPR-Waagen by Mettler-Toledo

Production of standards, samples and concentrations - fast and reliable

Automate the weighing processes in your laboratory - ideal also for sample prep at chromatography

laboratory balances
FlowSyn and FlowSyn Maxi

FlowSyn and FlowSyn Maxi by Uniqsis

Continuous Flow Chemistry Systems for reaction optimisation and scale up

Perform reactions up to 300°C and 100 bar from 0.1 - 100 ml /minute

flow reactors
Loading...

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.